Skip to main content

Caliper, Structural Genomix To Develop Protein Analysis Platform

NEW YORK, Jan 8 – Caliper and Structural Genomix have agreed to jointly develop a high throughput protein analysis system that will run on Caliper’s Microfluidics technology platform, the companies announced Monday.

In the collaboration, the companies will combine Caliper’s LabChip microfluidics technology and Structural Genomix’s high throughput X-ray crystallography methods of characterizing proteins. The combined product will put Caliper’s protein sizing and analysis assay into an automated 96-well sipper chip that can process hundreds of protein samples per day.  

This integrated microfluidics device, the companies said, will enable researchers to save the time and effort required by gel electrophoresis with a fast, automated and integrated system, designed to achieve high-level resolution to support highly precise purity analysis.

" Collaborations with leading technology developers such as Caliper will allow us to achieve our goal of bringing protein structure information to the forefront of the drug discovery process through leadership in technology development and integration,” Structural Genomix CEO Tim Harris said in a statement.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.